Angioimmunoblastic T-cell lymphoma with a clonal plasma cell proliferation that underwent immunoglobulin isotype switch in the skin, coinciding with cutaneous disease progression
Ana E. Suárez
Pathology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Search for more papers by this authorM.J. Artiga
Tumor Bank, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
Search for more papers by this authorCarlos. Santonja
Pathology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Search for more papers by this authorSantiago Montes-Moreno
Pathology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain
Search for more papers by this authorP. De Pablo
Dermatology Department, Hospital del Tajo, Madrid, Spain
Search for more papers by this authorLuis Requena
Dermatology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Search for more papers by this authorMiguel A. Piris
Pathology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain
Search for more papers by this authorCorresponding Author
Socorro M. Rodríguez-Pinilla
Pathology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Socorro María Rodriguez-Pinilla
Departamento de Anatomía Patológica, Hospital Universitario Fundación Jímenez Díaz, Av. Reyes Católicos, 2. 28040, Madrid, Spain
Tel: +34(9)15504800 ext. 2227
e-mail: [email protected]
Search for more papers by this authorAna E. Suárez
Pathology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Search for more papers by this authorM.J. Artiga
Tumor Bank, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
Search for more papers by this authorCarlos. Santonja
Pathology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Search for more papers by this authorSantiago Montes-Moreno
Pathology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain
Search for more papers by this authorP. De Pablo
Dermatology Department, Hospital del Tajo, Madrid, Spain
Search for more papers by this authorLuis Requena
Dermatology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Search for more papers by this authorMiguel A. Piris
Pathology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain
Search for more papers by this authorCorresponding Author
Socorro M. Rodríguez-Pinilla
Pathology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Socorro María Rodriguez-Pinilla
Departamento de Anatomía Patológica, Hospital Universitario Fundación Jímenez Díaz, Av. Reyes Católicos, 2. 28040, Madrid, Spain
Tel: +34(9)15504800 ext. 2227
e-mail: [email protected]
Search for more papers by this authorAbstract
Plasma cell proliferations in specific cutaneous lesions of angioimmunoblastic T-cell lymphoma(AITL) are very uncommon. Here, we report a case of clonal plasma cell proliferation in skin with heavy-chain-immunoglobulin-isotype-switch after cutaneous disease progression. Histopathologically, initial plaque lesions were suggestive of marginal-zone B-cell-lymphoma. Nevertheless, this 77-year-old lady was diagnosed with AITL after the progression of skin lesions from plaques to nodular tumors. A lymph node biopsy confirmed the diagnosis. Both cutaneous specimens showed a polymorphic cellular infiltrate with atypical T-cell-lymphocytes arranged in a pseudonodular pattern that expressed CD3, PD1 and BCL6, with patchy expression of CD30. Interestingly, a slight IgG-Lambda plasma cell component was seen at the periphery of the infiltrate in the first specimen which increased in number in the later nodular lesion, showing not only Lambda light chain restriction and IgG but also IgG4. PCR studies for IgH and TCR genes showed an IgH clonal peak on both skin lesions but not on lymph node biopsy. On the contrary, the same clonal TCR peak was found in the three specimens. Neoplastic follicular helper T-cells within cutaneous-specific microenvironment could be responsible for the modulation of the immunoglobulin isotype class switch change. Further studies are needed to support this hypothesis.
References
- 1Federico M, Rudiger T, Bellei M, et al. Clinicopathological characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clint Oncol 2013; 31: 240.
- 2Gaulard P, de Leval L. Follicular helper T cells: implications in neoplastic hematopathology. Semin Diagn Pathol 2011; 28: 202.
- 3de Leval L, Rickman DS, Thielen C, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007; 109: 4952.
- 4Lachenal F, Berger F, Ghesquieres H, et al. Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients. Medicine (Baltimore) 2007; 86: 282.
- 5Martel P, Laroche L, Courville P, et al. Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: a clinical, immunohistological, and molecular analysis. Arch Dermatol 2000; 136: 881.
- 6Attygalle R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002; 99: 627.
- 7Jayaraman AG, Cassarino D, Advani R, Kim YH, Tsai E, Kohler S. Cutaneous involvement by angioimmunoblastic T-cell lymphoma: a unique histologic presentation, mimicking an infectious etiology. J Cutan Pathol 2006; 33(Suppl 2): 6.
- 8Balaraman B, Conley JA, Sheinbein DM. Evaluation of cutaneous angioimmunoblastic T-cell lymphoma. J Am Acad Dermatol 2011; 65: 855.
- 9Attygalle AD, Kyriakou C, Dupuis J, et al. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol 2007; 31: 1077.
- 10Zettl A, Lee SS, Rudiger T, et al. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol 2002; 117: 368.
- 11Balague O, Martinez A, Colomo L, et al. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features. Am J Surg Pathol 2007; 31: 1310.
- 12Yang QX, Pei XJ, Tian XY, et al. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature. Diagn Pathol 2012; 7: 7.
- 13Huang J, Zhang PH, Gao YH, Qiu LG. Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma. Diagn Cytopathol 2012; 40: 346.
- 14Skugor ND, Peric Z, Vrhovac R, Radic-Kristo D, Kardum-Skelin I, Jaksic B. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma. Coll Antropol 2010; 34: 241.
- 15Tajika K, Tamai H, Mizuki T, Nakayama K, Yamaguchi H, Dan K. Epstein-Barr virus-related B-cell lymphoma of the skin which developed early after cord blood transplantation for angioimmunoblastic T-cell lymphoma. Rinsho Ketsueki 2010; 51: 138.
- 16Smeltzer JP, Viswanatha DS, Habermann TM, Patnaik MM. Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat. Am J Hematol 2012; 87: 927.
- 17Takahashi T, Maruyama R, Mishima S, et al. Small bowel perforation caused by Epstein-Barr virus-associated B cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma. J Clin Exp Hematop 2010; 50: 59.
- 18Matsue K, Itoh M, Tsukuda K, Kokubo T, Hirose Y. Development of Epstein-Barr virus-associated B cell lymphoma after intensive treatment of patients with angioimmunoblastic lymphadenopathy with dysproteinemia. Int J Hematol 1998; 67: 319.
- 19Liao YL, Chang ST, Kuo SY, et al. Angioimmunoblastic T-cell lymphoma of cytotoxic T-cell phenotype containing a large B-cell proliferation with an undersized B-cell clonal product. Appl Immunohistochem Mol Morphol 2010; 18: 185.
- 20Munemasa S, Sakai A, Sasaki N, et al. Angioimmunoblastic T-cell lymphoma complicated with EBV-associated B-cell lymphoma. Rinsho Ketsueki 2005; 46: 127.
- 21Xu Y, McKenna RW, Hoang MP, et al. Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: a case report and review of the literature. Am J Clin Pathol 2002; 118: 848.
- 22van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257.
- 23Botros N, Cerroni L, Shawwa A, et al. Cutaneous manifestations of angioimmunoblastic T-cell lymphoma: clinical and pathological characteristics. Am J Dermatopathol 2015; 37: 274.
- 24Ortonne N, Dupuis J, Plonquet A, et al. Characterization of CXCL13+ neoplastic t cells in cutaneous lesions of angioimmunoblastic T-cell lymphoma (AITL). Am J Surg Pathol 2007; 31: 1068.
- 25Cetinozman F, Jansen PM, Willemze R. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma. Am J Surg Pathol 2012; 36: 109.
- 26Shulman Z, Gitlin AD, Weinstein JS, et al. Dynamic signaling by T follicular helper cells during germinal center B cell selection. Science 2014; 345: 1058.
- 27Iqbal J, Weisenburger DD, Greiner TC, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010; 115: 1026.
- 28Kaffenberger B, Haverkos B, Tyler K, Wong HK, Porcu P, Gru AA. Extranodal marginal zone lymphoma-like presentations of angioimmunoblastic T-cell lymphoma: a t-cell lymphoma masquerading as a B-cell lymphoproliferative disorder. Am J Dermatopathol 2015; 37: 604.
- 29Bayerl MG, Hennessy J, Ehmann WC, Bagg A, Rosamilia L, Clarke LE. Multiple cutaneous monoclonal B-cell proliferations as harbingers of systemic angioimmunoblastic T-cell lymphoma. J Cutan Pathol 2010; 37: 777.
- 30Brenner I, Roth S, Puppe B, Wobser M, Rosenwald A, Geissinger E. Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression. Mod Pathol 2013; 26: 1568.
- 31van Maldegem F, van Dijk R, Wormhoudt TA, et al. The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment. Blood 2008; 112: 3355.
- 32Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clin Exp Allergy 2009; 39: 469.
- 33Nirula A, Glaser SM, Kalled SL, Taylor FR. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol 2011; 23: 119.
- 34Jain S, Chen J, Nicolae A, et al. IL-21-driven neoplasms in SJL mice mimic some key features of human angioimmunoblastic T-cell lymphoma. Am J Pathol 2015; 185: 3102.